News
Discover how biotechs and big pharma are developing novel treatments for high cholesterol with a range of different targets.
Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and ...
Take a closer look at London's biotech hub – renowned for its thriving life sciences ecosystem and world-class infrastructure ...
Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results